Clinicians are generally reluctant to start ATT on positive TB testing alone,16,25 in accordance to the current recommendations.26, 27, 28 This dilemma is heightened when uveitis is non-responsive to corticosteroids or when biologics such as anti-TNF therapy are considered.29 This evidence concerns the gene TNF and uveitis.